Abstract:Background Osteoporosis is a systemic skeletal disorder characterized by decreased bone density and the degradation of bone tissue microarchitecture. Ginsenoside Rg1, derived from Panax ginseng , has been a part of traditional Chinese medicine in China for centuries, particularly for treating osteoporosis. However, there remains limited research on the osteogenic potential of Rg1 within the glucocorticoid-induced osteoporosis (GIOP) model and its specific mechanisms. Purpose The primary objective of this study is to investigate the osteogenic potential of Rg1 within the GIOP model and explore the signaling pathways associated with its in vivo and in vitro effects. Methods Cell proliferation, differentiation and mineralization were evaluated by the Cell counting kit 8(CCK8) assay, alkaline phosphatase (ALP) test and Alizarin Red S staining, respectively. The qPCR technique was used to determine the relative expression of mRNA and the western blot was used to determine the relative expression of protein. In vivo experiments, spinal vertebrae staining in zebrafish larvae was accomplished by alizarin red S staining. Results Zebrafish larvae's hatching, survival, malformation, and heart rate were unaffected by 50 μM of Rg1 in vivo , while the MEC3T3-E1 cell line's proliferation was unaffected by 50 μM of Rg1 in vitro . Meanwhile, Rg1 was shown to improve osteogenic differentiation or bone formation as well as the level of mRNA expression of osteogenic markers in vivo and in vitro . Treatment with Rg1 significantly increased the expression of G protein-coupled estrogen receptor (GPER) and pAKT. In addition, the GPER inhibitor G15 could significantly reduce the mRNA and protein expression levels of GPER and phosphorylated AKT, LY294002, a PI3K/AKT pathway inhibitor, markedly suppresses the expression of phosphorylated AKT, yet shows no significant impact on GPER expression. Both G15 and LY294002 can significantly blocked the Rg1-mediated enhancement of osteogenesis capacity in the GIOP model. In contrast, when both the agonists G1 of GPER and LY294002 were added, G1 increased the relative expression of mRNA and protein of GPER, but not the expression of osteogenic capacity and osteogenic markers. Conclusions This study investigates the mineralization effects and mechanisms of Ginsenoside Rg1 both in vitro and in vivo . For the first time, we propose that Rg1 might regulate osteogenesis by modulating AKT phosphorylation through mediating GPER expression within the PI3K/AKT pathway in the GIOP model. This discovery introduces novel targets and avenues for osteoporosis treatment.

Ginsenoside Rg1 promotes non-rapid eye movement sleep via inhibition of orexin neurons of the lateral hypothalamus and corticotropin-releasing hormone neurons of the paraventricular hypothalamic nucleus

Ginsenoside Rg1 Promotes Sleep in Rats by Modulating the Noradrenergic System in the Locus Coeruleus and Serotonergic System in the Dorsal Raphe Nucleus

Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway.

Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model

Ginsenoside Rg5 Improves Sleep by Regulating Energy Metabolism in Sleep-Deprived Rats

Mechanisms underlie ginsenosides regulating spontaneous sleep architecture in rats

Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis.

Actions of Ginsenosides on Sleep Architecture and Cortical Electroencephalogram Power Spectrum in Rats

Ginsenoside Rg1 alleviates sleep deprivation-induced learning and memory impairment by inhibiting excessive neuronal apoptosis in zebrafish

Mechanism of action of Panax ginseng alcohol extract based on orexin-mediated autophagy in the treatment of sleep and cognition in aged sleep-deprived rats

The Rostromedial Tegmental Nucleus is Essential for Non-Rapid Eye Movement Sleep

The Effects of Ginsenoside Rb1 on EEG of Sleep and Pro-inflammatory Cytokines Gene Expression in Brain of Rats

Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.

Genistein induces non-rapid eye movement sleep in mice

GABAergic neurons in the rostromedial tegmental nucleus are essential for rapid eye movement sleep suppression

Paeoniflorin Promotes Non-rapid Eye Movement Sleep via Adenosine A1 Receptors.

Ginsenoside Rg1 Improves Male Copulatory Behavior Via Nitric Oxide/cyclic Guanosine Monophosphate Pathway.

Selectively driving cholinergic fibers optically in the thalamic reticular nucleus promotes sleep

Extract of Ganoderma lucidum prolongs sleep time in rats.

Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER

GABA Transporter-1 Inhibitor NO-711 Alters the EEG Power Spectra and Enhances Non-Rapid Eye Movement Sleep During the Active Phase in Mice.